EHealth Selling And Marketing Expenses from 2010 to 2024
| EHTH Stock | USD 5.65 0.15 2.73% |
Selling And Marketing Expenses | First Reported 2006-03-31 | Previous Quarter 26.8 M | Current Value 29.7 M | Quarterly Volatility 22.7 M |
Check EHealth financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EHealth's main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.9 M, Interest Expense of 11.5 M or Selling General Administrative of 46.8 M, as well as many indicators such as Price To Sales Ratio of 0.51, Dividend Yield of 0.0116 or PTB Ratio of 0.26. EHealth financial statements analysis is a perfect complement when working with EHealth Valuation or Volatility modules.
EHealth | Selling And Marketing Expenses |
Latest EHealth's Selling And Marketing Expenses Growth Pattern
Below is the plot of the Selling And Marketing Expenses of eHealth over the last few years. It is EHealth's Selling And Marketing Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EHealth's overall financial position and show how it may be relating to other accounts over time.
| Selling And Marketing Expenses | 10 Years Trend |
|
Selling And Marketing Expenses |
| Timeline |
EHealth Selling And Marketing Expenses Regression Statistics
| Arithmetic Mean | 115,711,620 | |
| Geometric Mean | 91,375,841 | |
| Coefficient Of Variation | 63.08 | |
| Mean Deviation | 63,782,077 | |
| Median | 75,571,000 | |
| Standard Deviation | 72,990,489 | |
| Sample Variance | 5327.6T | |
| Range | 252.3M | |
| R-Value | 0.86 | |
| Mean Square Error | 1495.9T | |
| R-Squared | 0.74 | |
| Significance | 0.00004 | |
| Slope | 14,033,118 | |
| Total Sum of Squares | 74586.6T |
EHealth Selling And Marketing Expenses History
About EHealth Financial Statements
Investors use fundamental indicators, such as EHealth's Selling And Marketing Expenses, to determine how well the company is positioned to perform in the future. Although EHealth's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Selling And Marketing Expenses | 173.3 M | 182 M |
Currently Active Assets on Macroaxis
When determining whether eHealth offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ehealth Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ehealth Stock:Check out the analysis of EHealth Correlation against competitors. For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Insurance Brokers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EHealth. If investors know EHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.108 | Earnings Share (2.62) | Revenue Per Share 16.016 | Quarterly Revenue Growth (0.1) | Return On Assets (0.01) |
The market value of eHealth is measured differently than its book value, which is the value of EHealth that is recorded on the company's balance sheet. Investors also form their own opinion of EHealth's value that differs from its market value or its book value, called intrinsic value, which is EHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EHealth's market value can be influenced by many factors that don't directly affect EHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if EHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.